- Coordinator
- FARM-ID - Associacao da Faculdade de Farmacia para a Investigacao e Desenvolvimento, Portugal
- Runs
- 1 October 2025 to 30 September 2029
- Status
- Running
- EU funding
- €2.4m
- Total cost
- —
- Partners
- 17 organisations in 10 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101226058
What the project is doing
In the project's own words, from its summary on CORDIS.
Innovation in the chemical sciences is bound to iInnovation in the chemical sciences is bound to impact on Healthcare and Society. Supported by improved analytical methods and automation, brute force and large-scale experimentation have been playing an important role in generating volumes of chemical and biological data. These data now enable the support to decision making through machine learning/artificial intelligence (ML/AI) algorithms.
In doing so, such algorithms help in the design and prioritization of experiments. As a result, we are witnessing a renaissance of ML/AI for accelerating chemistry, as in planning retrosyntheses, predicting reaction products, designing drug leads and materials de novo, and deconvoluting drug targets among others. Despite the chemistry advances leveraged by ML/AI, one can argue that not all research questions and findings benefit from the availability of big data (e.g., some discoveries are serendipitous).
Here we argue that the current ML/AI toolkit excels in scenarios (big data) that do not entirely map onto daily practice (low and sparse data, often out of training set distribution). Thus, the scientific potential of ML/AI is not fully realized when state-of-the-art tools are implemented and primed for big data and highly charted search spaces. The disconnect between what is feasible and generally needed is apparent and is impacting our ability to advance the chemical sciences at a faster pace.
In LowDataML we propose a suite of intersectional and transdisciplinary research projects that will create a new breed of scientists. Through an extensive training program, we will deliver 10 PhDs to the European R&D ecosystem, who are experts in low data ML with domain knowledge in synthetic organic chemistry and drug discovery. Further, the projects seamlessly integrate together and focus on: i) real world needs; ii) sustainability by minimising cost, time and materials consumption, with special focus on ecofriendly research practices.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| FARM-ID - Associacao da Faculdade de Farmacia para a Investigacao e Desenvolvimento | Lisbon | Portugal | Coordinator |
| The Governing Council of the University of Toronto | Toronto | Canada | Associatedpartner |
| Ecole Polytechnique Federale De Lausanne | Lausanne | Switzerland | Associatedpartner |
| Ibm Research GmbH | Rueschlikon | Switzerland | Associatedpartner |
| European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric) | Berlin | Germany | Associatedpartner |
| Freie Universitaet Berlin | Berlin | Germany | Associatedpartner |
| Universitaet Muenster | Muenster | Germany | Participant |
| Idryma Iatroviologikon Ereunon Akademias Athinon | Athina | Greece | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Arquimea Research Center SL | San Cristobal De La Laguna | Spain | Associatedpartner |
| Universidad Complutense De Madrid | Madrid | Spain | Associatedpartner |
| Ben-Gurion University of the Negev | Beer Sheva | Israel | Participant |
| Technische Universiteit Eindhoven | Eindhoven | Netherlands | Participant |
| Fundacao Gimm - Gulbenkian Institute for Molecular Medicine | Lisboa | Portugal | Associatedpartner |
| Faculdade de Farmácia da Universidade de Lisboa | Lisboa | Portugal | Associatedpartner |
| Astrazeneca AB | Sodertaelje | Sweden | Participant |
| The Chancellor Masters and Scholars of the University of Cambridge | Cambridge | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI